ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,995.54
      0.38%
      US Tech 100
      20,561.20
      0.10%
      Dow Jones
      43,988.99
      0.59%
      Brent Oil
      73.885
      -2.09%
      Bitcoin
      76,529.88
      0.83%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Cel Sci Corporation New (CVM)

      7. Cel Sci Corporation New (CVM) News

      CVM

      Cel Sci (CVM)

      Cel Sci Corporation New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:CVM
      DateTimeSourceHeadlineSymbolCompany
      11/08/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CVMCel Sci Corporation New
      11/07/20248:15AMBusiness WireU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025AMEX:CVMCel Sci Corporation New
      10/30/20245:21PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CVMCel Sci Corporation New
      10/25/20245:17PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CVMCel Sci Corporation New
      10/22/20249:15AMBusiness WireFDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer PatientsAMEX:CVMCel Sci Corporation New
      10/11/20245:00PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:CVMCel Sci Corporation New
      10/10/20244:05PMEdgar (US Regulatory)Form AW - Amendment Withdrawal RequestAMEX:CVMCel Sci Corporation New
      10/08/20245:13PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CVMCel Sci Corporation New
      10/01/20249:13AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      10/01/20249:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      10/01/20248:58AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      10/01/20246:00AMBusiness WireCEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck CancerAMEX:CVMCel Sci Corporation New
      09/16/20247:30AMBusiness WireCEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and RadiationAMEX:CVMCel Sci Corporation New
      09/10/20249:32AMBusiness WireCEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 CongressAMEX:CVMCel Sci Corporation New
      09/04/20249:00AMBusiness WireThe UK’s Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine® One Step Closer to Future Marketing ClearanceAMEX:CVMCel Sci Corporation New
      08/30/20244:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:CVMCel Sci Corporation New
      08/15/20248:00AMBusiness WireCEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
      08/14/20244:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CVMCel Sci Corporation New
      07/29/20245:16PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      07/29/20244:05PMBusiness WireCEL-SCI Announces Closing of $10.8 Million OfferingAMEX:CVMCel Sci Corporation New
      07/29/20247:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
      07/26/20245:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      07/26/202411:52AMBusiness WireCEL-SCI Announces Pricing of $10.8 Million OfferingAMEX:CVMCel Sci Corporation New
      07/26/20248:23AMBusiness WireCEL-SCI’s Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical ResultsAMEX:CVMCel Sci Corporation New
      07/08/20249:15AMBusiness WireCEL-SCI Appoints Robert Watson as Chairperson of the BoardAMEX:CVMCel Sci Corporation New
      06/18/20248:00AMBusiness WireCEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target PopulationAMEX:CVMCel Sci Corporation New
      06/06/20247:00AMBusiness WireDr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical AdvisorAMEX:CVMCel Sci Corporation New
      05/16/20249:00AMBusiness WireCEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
      05/15/20244:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CVMCel Sci Corporation New
      05/10/20249:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
       Showing the most relevant articles for your search:AMEX:CVM

      Your Recent History

      BIT
      Q00319
      Leonteq Securities
      Delayed Upgrade Clock